Is Picard Medical, Inc. (PMI) a Buy, Sell, or Hold?
Picard Medical, Inc.
AMEX:PMI
$0.14 USD
$0.0 (-1.75%)
- Volume
- 0
- Average Volume
- 29.47M
- Market Capitalization
- $218.4M
- P/E Ratio
- -0.31
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $13.68
- Year Low
- $0.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.75
Industry, Sector & symbol
| Stock Exchange | AMEX |
| CEO | Patrick N. J. Schnegelsberg |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | PMI |
| CUSIP | 71953R108 |
| CIK | 0002030617 |
| Web | https://www.picardmedical.com |
| Phone | 520 545 1234 |
| Currency | USD |
| Employees | 75 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | -2.26 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.75 |
| Quick Ratio | 0.16 |
| Cash Ratio | 0.01 |
Sales & Book Value
| Annual Sales | $4.94M |
| Price / Sales | 39.88 |
| Cash Flow | -0.23 |
| Price / Cash Flow | -12.66 |
| Price / Book | -7.20 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 1 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.37 |
| Trailing P/E Ratio | -0.31 |
| PEG Ratio | 0.01 |
| P/E Growth | 0.01 |
| Net Income | $-27M |
| Net Margin | -545.02% |
| Pretax Margin | -531.06% |
| Return on Equity | 499.20% |
| Return on Assets | -266.05% |
Financials Score
| AltmanZ Score | -7.00 |
| Piotroski Score | 4.00 |
| Working Capital | -3.15M |
| Total Assets | 11.22M |
| Ebit | -24.25M |
| Market Cap | 222.14M |
| Total Liabilities | 12.67M |
Poll Results
About Picard Medical, Inc. (AMEX:PMI) Stock
Picard Medical, Inc., through its associated companies, is dedicated to the entire process of medical device commercialization, from initial design and manufacturing to production, distribution, marketing, and sales. A key product in its portfolio is the SynCardia TAH, a sophisticated total artificial heart specifically engineered to supplant a failing human heart in individuals afflicted with advanced cardiac disease. The firm's market presence extends across the United States, Europe, and other international regions. Established in 2021, Picard Medical maintains its primary operations in Tucson, Arizona, functioning as a direct subsidiary of Hunniwell Picard I, Llc. ...
Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting
2026-07-13 08:00:00
Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration
Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting
2026-07-02 08:00:00
- Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration- - Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration-
The WSJ Leadership Institute Names Philip Morris International Among “Best Companies For the Future”
2026-06-26 05:00:00
Philip Morris International Inc. (PMI) (NYSE: PM) has been named in the WSJ Leadership Institute's inaugural âBest Companies for the Futureâ ranking, which
Kuehn Law Encourages Investors of Picard Medical, Inc. to Contact Law Firm
2026-06-25 15:37:00
NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical, Inc. (NYSE American: PMI) breached their fiduciary duties to shareholders.
Perseverance Metals Appoints Isabelle Cadieux as Independent Director
2026-06-25 07:30:00
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2026) - Perseverance Metals Inc. (TSXV: PMI) ("Perseverance", "PMI" or the "Company") is pleased to announce that its Board of Directors has appointed Isabelle Cadieux as an Independent Director, effective immediately. Ms. Cadieux, a Professional Geologist in the province of Québec, has over 35 years of experience in mineral exploration and the mining sector in both technical and financial roles, including serving for over 20 years as the Managing Director, Investment at SIDEX - a Québec institutional fund focused on exploration-stage companies in the province.
Picard Medical Announces Leadership Transition
2026-06-24 08:00:00
TUCSON, Ariz., June 24, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC (“SynCardia”), maker of the world's first total artificial heart approved by both the U.S. Food and Drug Administration and Health Canada, today announced a leadership transition.
U.S. Bank Names Eric Levine to Lead Healthcare Payments
2026-06-23 09:00:00
MINNEAPOLIS--(BUSINESS WIRE)--Eric Levine has joined U.S. Bank to lead the bank's strategy to deliver more connected treasury, payments and merchant solutions to healthcare organizations. As head of healthcare for Payments: Merchant and Institutional (PMI) Sales Distribution, Levine will advance the company's focus on aligning cross-bank teams to deliver tailored solutions to the healthcare industry, including hospital systems, payers, medical device manufacturers and life sciences companies. L.
WSJ Intelligence Study: Uniquely Human Skills Deemed "Non-Replicable" in Automated Future
2026-06-23 06:00:00
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International (PMI) (NYSE: PM) and WSJ Intelligence, the in-house thought leadership consultancy for The Wall Street Journal's commercial sales organization, today revealed topline findings from a forthcoming study at Journal House during the Cannes Lions International Festival of Creativity. The study delivered a clear takeaway for global businesses: human cognition must be the absolute forefront of the modern corporate landscape. The findings show.
Frequently Asked Questions
-
What is the current Picard Medical, Inc. (PMI) stock price?
-
Picard Medical, Inc.(AMEX:PMI) stock price is $0.14 in the last trading session. During the trading session, PMI stock reached the peak price of $13.68 while $0.11 was the lowest point it dropped to. The percentage change in PMI stock occurred in the recent session was --1.75% while the dollar amount for the price change in PMI stock was -$-0.0.
-
PMI's industry and sector of operation?
-
The AMEX listed PMI is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of PMI?
-
Yuncai Fang | Interim CEO & Chairman of the Board
Frank Tinker | Chief Technology Officer of SynCardia Systems, LLC
Bernard Skaggs | Chief Financial Officer
Matthew Schuster | Chief Operating Officer
Patrick N. J. Schnegelsberg | Chief Executive Officer & Director -
How many employees does PMI have?
-
Number of PMI employees currently stands at 75. PMI operates from 1992 E Silverlake Road, Tucson, Arizona 85713, USA, Tucson, AZ 85713, US.
-
Link for PMI official website?
-
Official Website of PMI is: https://www.picardmedical.com
-
How do I contact PMI?
-
PMI could be contacted at phone #520 545 1234 and can also be accessed through its website. PMI operates from 1992 E Silverlake Road, Tucson, Arizona 85713, USA, Tucson, AZ 85713, US.
-
How many shares of PMI are traded daily?
-
The average number of PMI shares traded daily for last 3 months was 29.47M.
-
What is the market cap of PMI currently?
-
The market value of PMI currently stands at $218.4M with its latest stock price at $0.14